We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement
Analytical Cannabis Logo
×
Home > News
Cannabis & Psychedelics News

A Big Step Forward for Medical Marijuana

Medical marijuana has picked up considerable momentum after a U.S. FDA advisory panel unanimously recommended approval of GW Pharmaceuticals' epilepsy medication, Epidolex.

Read More

Aurora Acquires Anandia Labs for $115M

Anandia plans to accelerate their current breeding efforts to create the next-generation of cannabis plants and, expand their testing capabilities.

Read More

Medical Cannabis and the Challenge for Regulation of Medicines

Reviews of scientific evidence show promising findings for some, but not all, conditions for which cannabis is considered a treatment – and this evidence is difficult to untangle.

Read More

Unlocking the Power of Lebanese Cannabis

Can Lebanon-grown cannabis provide an alternative treatment for certain chronic ailments? Researchers want to find out.

Read More

Multiple Sclerosis Study Could Push Cannabis Compounds Closer to FDA Approval

MMJ is seeking to scientifically assess and prove the effectiveness of their THC/CBD compounds treating and preventing symptoms associated with multiple sclerosis.

Read More

Advancing Cannabis Testing Across Canada

Canopy Growth and MSC will work together to pioneer new and standardized testing methods to analyse potency, terpene profiling, pesticides, heavy metals, and mycotoxins as required by Health Canada regulatory standards.

Read More

Mobile Cannabis Extraction Module Makes Its Way To British Columbia

Quadron Cannatech has announced that it has completed the sale of its first mobile extraction module to TLC Botanicals, located in Langley, British Columbia.

Read More

Building the Cannabis Strains of the Future

A new partnership has plans to improve cannabis plant yield, add diversity, promote immunity, and modify the physical and chemical traits of cannabinoid expressing plants.

Read More

Precise Cannabinoid Dosing and Tackling the Opioid Epidemic

Novel cannabinoid formulation, RAPID, is being tested for the treatment of stress and anxiety relief, cognitive focus, various kinds of pain and, migraines and could help curb opioid use.

Read More

 
Advertisement